Karen Glass, assistant professor in the Department of Pharmaceutical Sciences at Albany College of Pharmacy and Health Sciences’ Vermont Campus, has been awarded a three-year NIH research grant totaling $353,400. Her research is aimed at identifying new ways to prevent and treat Acute Myeloid Leukemia (AML). “There is no single factor, but rather a series of events, which leads to a disease such as AML,” said Dr. Glass. “If we can better understand the basic mechanisms controlling gene expression and how chromosomal translocations lead to AML and other cancers, then we will be able to diagnose and treat AML patients more effectively. We may also be able to apply this knowledge in the treatment of other cancers and diseases.”
Read the full press release.
Learn more about Karen Glass’ research.
Next post: VT EPSCoR Funding Opportunities